Literature DB >> 15242420

Mortality in Parkinson's disease and its association with dementia and depression.

T A Hughes1, H F Ross, R H S Mindham, E G S Spokes.   

Abstract

OBJECTIVE: To compare the mortality rate in Parkinson's disease (PD) with a control group without PD, and to assess the relationship between mortality and features of PD.
MATERIAL AND METHODS: Ninety PD patients and 50 controls, mortality ascertained at 11 years follow-up.
RESULTS: The hazard ratio (HR) for mortality in PD patients compared with controls was 1.64 (95% CI: 1.21-2.23). Multivariate analysis showed age, dementia and depression were independent predictors of mortality but age at onset of PD and severity of neurological symptoms were not. The HR for age was 1.09 (95% CI: 1.05-1.13), for dementia 1.94 (95% CI: 1.26-2.99), and for depression 2.66 (95% CI: 1.59-4.44).
CONCLUSION: Mortality in PD is increased compared with controls. Psychological variables are important predictors of mortality in PD.

Entities:  

Mesh:

Year:  2004        PMID: 15242420     DOI: 10.1111/j.1600-0404.2004.00292.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  51 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Jennifer G Goldman; Holly Weis; Glenn Stebbins; Bryan Bernard; Christopher G Goetz
Journal:  Mov Disord       Date:  2012-07-06       Impact factor: 10.338

Review 3.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

4.  Impaired Curve Negotiation in Drivers with Parkinson's Disease.

Authors:  Ergun Y Uc; Matthew Rizzo; Elizabeth Dastrup; Jondavid Sparks; Steven W Anderson; Robert L Rodnitzky; Jeffrey D Dawson
Journal:  Turk Noroloji Dergisi       Date:  2009-01-19

Review 5.  [Diagnosis and clinical therapy for Parkinson's disease].

Authors:  S Wenzel; B Mollenhauer; C Trenkwalder
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

6.  Estimated life expectancy of Parkinson's patients compared with the UK population.

Authors:  Lianna S Ishihara; Anne Cheesbrough; Carol Brayne; Anette Schrag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-30       Impact factor: 10.154

Review 7.  [Parkinson's disease in the elderly].

Authors:  Rüdiger Lange; Frank Erbguth
Journal:  Z Gerontol Geriatr       Date:  2017-07-19       Impact factor: 1.281

Review 8.  Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.

Authors:  Barbara Connolly; Susan H Fox
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 9.  Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Petros Skapinakis; Eleni Bakola; Georgia Salanti; Glyn Lewis; Athanasios P Kyritsis; Venetsanos Mavreas
Journal:  BMC Neurol       Date:  2010-06-21       Impact factor: 2.474

10.  Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study.

Authors:  R Scott Mackin; Patricia Areán; Alexandra Elite-Marcandonatou
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.